A Randomized, Phase II Trial of Cabozatinib and Cabozaninib plus Nivolumab vs Standard Chemotherapy in Patients with previously treated NSCLC
Read more about this trial →← Back to available clinical trials
A Randomized, Phase II Trial of Cabozatinib and Cabozaninib plus Nivolumab vs Standard Chemotherapy in Patients with previously treated NSCLC
Read more about this trial →